Contact
Please use this form to send email to PR contact of this press release:
Dr. Kurt Jaeckle to Lead Phase III Clinical Trial of Novel Drug VAL-083 for Late-Stage Glioblastoma
TO:
Janina Hecht
Atlantic Health System
(908) 522-2142